Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Davis

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Drug Design, Development and Therapy|December 22, 2017
Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapyElizabeth J Davis, Rashmi Chugh
Current Treatment Options in Oncology|October 17, 2024
Neoadjuvant Chemotherapy for Adults with Osteogenic SarcomaMichael J Robinson, Elizabeth J Davis
Personalized Medicine|September 2, 2017
Enabling a genetically informed approach to cancer medicine: evaluation of the impact of comprehensive tumor sequencingElizabeth J Davis, Douglas B Johnson
The Lancet. Oncology|February 13, 2019
Targeting tissue factor in advanced solid tumoursElizabeth J Davis, Douglas B Johnson
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Toxicities Associated With PD-1/PD-L1 BlockadeDaniel Y Wang, Douglas B Johnson, Elizabeth J Davis
Current Problems in Cancer|November 4, 2024
Palliative care integration for patients on phase I cancer clinical trialsAnna-Carson R Uhelski, Margaret Wheless, Elizabeth J Davis, et al.
Cancer|April 18, 2018
Melanoma: What do all the mutations mean?Elizabeth J Davis, Douglas B Johnson, Jeffrey A Sosman, et al.
The Oncologist|June 20, 2019
Empiric Therapy with BRAF and MEK Inhibitors in Metastatic MelanomaChristopher G Cann, Benjamin F Tillman, Elizabeth J Davis, et al.
Vaccine|January 5, 2012
Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United StatesGirishanthy Krishnarajah, Elizabeth J Davis, Ying Fan, et al.
Current Medical Research and Opinion|September 8, 2009
Glaucoma medication persistence with a fixed combination versus multiple bottlesEve J Higginbotham, Jan Hansen, Elizabeth J Davis, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Drug Design, Development and Therapy|December 22, 2017
Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapyElizabeth J Davis, Rashmi Chugh
Current Treatment Options in Oncology|October 17, 2024
Neoadjuvant Chemotherapy for Adults with Osteogenic SarcomaMichael J Robinson, Elizabeth J Davis
Personalized Medicine|September 2, 2017
Enabling a genetically informed approach to cancer medicine: evaluation of the impact of comprehensive tumor sequencingElizabeth J Davis, Douglas B Johnson
The Lancet. Oncology|February 13, 2019
Targeting tissue factor in advanced solid tumoursElizabeth J Davis, Douglas B Johnson
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Toxicities Associated With PD-1/PD-L1 BlockadeDaniel Y Wang, Douglas B Johnson, Elizabeth J Davis
Current Problems in Cancer|November 4, 2024
Palliative care integration for patients on phase I cancer clinical trialsAnna-Carson R Uhelski, Margaret Wheless, Elizabeth J Davis, et al.
Cancer|April 18, 2018
Melanoma: What do all the mutations mean?Elizabeth J Davis, Douglas B Johnson, Jeffrey A Sosman, et al.
The Oncologist|June 20, 2019
Empiric Therapy with BRAF and MEK Inhibitors in Metastatic MelanomaChristopher G Cann, Benjamin F Tillman, Elizabeth J Davis, et al.
Vaccine|January 5, 2012
Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United StatesGirishanthy Krishnarajah, Elizabeth J Davis, Ying Fan, et al.
Current Medical Research and Opinion|September 8, 2009
Glaucoma medication persistence with a fixed combination versus multiple bottlesEve J Higginbotham, Jan Hansen, Elizabeth J Davis, et al.
Pageof 5